Effects of Teriparatide and Alendronate on Functional Recovery from Spinal Cord Injury and Postinjury Bone Loss
Open Access
- 3 February 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (2) , 342
Abstract
Objectives: This study evaluated the efficacy of teriparatide (TPTD) and alendronate (ALN) in mitigating bone loss, enhancing bone structure, and facilitating motor function recovery following spinal cord injury (SCI). Methods: All the rats were allocated into four groups: a sham surgery group (SHAM group), a normal saline group (SCI + NS group), a TPTD treatment group after SCI (SCI + TPTD group), and an ALN treatment group after SCI (SCI + ALN group). The Basso, Beattie, and Bresnahan (BBB) scores and gait analyses were used to assess the motor abilities of rats following SCI and the effects of treatment. HE staining, Masson’s trichrome staining, and LFB staining were performed to evaluate the extent of spinal cord tissue damage. Micro-CT was used to measure 12 bone-related parameters of the proximal tibia and create 3D images, and structural changes in the proximal tibial bone tissue were observed under a light microscope after HE staining. Results: After 12 weeks of treatment, the micro-CT data indicated that TPTD significantly increased key bone indicators, such as bone mineral density, after SCI (p < 0.01), whereas ALN did not significantly improve these indicators (p > 0.05). Compared with the SCI + NS group, the SCI + TPTD group presented significantly greater BBB scores and near-normal gait parameters (p < 0.05). Analyses of pathological sections revealed that TPTD significantly reduced the cavity area in the spinal cord after SCI, decreased the proportion of scar tissue, and increased the retention of neural myelin (p < 0.05). However, ALN had no significant effect on these indicators (p > 0.05). Conclusions: TPTD was more effective than ALN at mitigating bone loss and promoting motor function recovery after SCI, and it demonstrated significant advantages in reducing spinal cord damage and improving tissue structure.Keywords
Funding Information
- National Natural Science Foundation of China (31701048)
- Prof. Benchao Shi (31701048)
This publication has 59 references indexed in Scilit:
- Animal models of compression spinal cord injuryJournal of Neuroscience Research, 2022
- Evaluating Gait and Locomotion in Rodents with the CatWalkCurrent Protocols, 2021
- The leading edge: Emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injuryStem Cells Translational Medicine, 2020
- Effects of Teriparatide and Vibration on Bone Mass and Bone Strength in People with Bone Loss and Spinal Cord Injury: A Randomized, Controlled TrialJournal of Bone and Mineral Research, 2018
- Treatment of OsteoporosisJAMA, 2018
- Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJournal of Bone and Mineral Research, 2012
- Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injuryOsteoporosis International, 2010
- Changes in Bone Mass, Bone Structure, Bone Biomechanical Properties, and Bone Metabolism after Spinal Cord Injury: A 6-Month Longitudinal Study in Growing RatsCalcified Tissue International, 2007
- Differences of bone mass and bone structure in osteopenic rat models caused by spinal cord injury and ovariectomyOsteoporosis International, 2007
- Spinal cord injury causes more damage to bone mass, bone structure, biomechanical properties and bone metabolism than sciatic neurectomy in young ratsOsteoporosis International, 2006